振德醫療(603301.SH)業績快報:一季度淨利升180.63%至8591.29萬元
格隆匯4月27日丨振德醫療(603301.SH)公佈,2020年4月26日,公司關注到有媒體發佈了《“越城製造”:千磨萬擊還堅勁—越城區先進製造業高質量發展紀事》報道,其中提到公司一季度銷售額達4.32億元,同比增長76.4%,預計全年銷售額將突破30億元。相關報道已被部分網站轉載。報道內容與事實不符,容易造成誤導。
為維護廣大投資者的利益,避免投資者對上述報道的內容產生誤讀,公司就報道內容進行澄清並公告公司2020年一季度業績快報。
公司預計2020年一季度實現營業總收入7.09億元,同比增長112.34%;歸屬於上市公司股東的淨利潤8591.29萬元,同比增長180.63%;基本每股收益0.61元。一季度經營業績大幅增長主要系2020年一季度公司因疫情影響公司防護用品產品銷售大幅增加。未來是否繼續保持大幅度增長存在不確定性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.